Longitudinal studies of cardiac troponin I in a large cohort of healthy children

Clinical Chemistry

Volumn 58, Issue 12, 2012, Pages 1665-1672

  Koerbin, Gus ^a,b   Potter, Julia M ^a,c   Abhayaratna, Walter P ^c,d   Telford, Richard D ^c   Badrick, Tony ^e   Apple, Fred S ^f   Jaffe, Allan S ^g   Hickman, Peter E ^a,c  

^a ACT Pathology   (Australia)

^b UNIVERSITY OF CANBERRA   (Australia)

^c The Australian National University   (Australia)

^d CANBERRA HOSPITAL   (Australia)

^e BOND UNIVERSITY   (Australia)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^g MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE; TROPONIN I;

ARTICLE; BIOASSAY; BLOOD SAMPLING; CARDIOVASCULAR SYSTEM EXAMINATION; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; EXERCISE; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; LIMIT OF DETECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PRESCHOOL CHILD; REPRODUCIBILITY; SCHOOL CHILD; SENSITIVITY ANALYSIS;

CHILD; FEMALE; HUMANS; LIMIT OF DETECTION; LONGITUDINAL STUDIES; MALE; REFERENCE VALUES; TROPONIN I;

EID: 84870314240     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.192054     Document Type: Article

References (27)

1. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007;28:2525-38.
2. Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 2007;53:552-74.
3. Apple FS, Jesse RL, Newby LK, Wu AHB, Christenson RH. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage laboratory medicine practice guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem 2007;53:547-51.
4. Apple FS, Murakami MAM, Quist HH, Pearce LA, Wieczorek S, Wu AHB. Prognostic value of the Ortho Vitro cardiac troponin I assay in patients with symptoms of myocardial ischemia. Risk stratification using European Society of Cardiology/ American College of Cardiology recommended cutoff values. Am J Clin Pathol 2003;120:114-20.
5. James S, Armstrong P, Califf R, Simoons ML, Venge P, Wallentin L, Lindahl B. Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial. Am J Med 2003;115:178-84.
6. Zethelius B, Johnston N, Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men. A community-based cohort study. Circulation 2006;113:1071-8.
7. Wallace TW, Abdullah SM, Drazner MH, Das SR, Khera A, McGuire DK, et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006;113:1958-65.
8. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010;304:2503-12.
9. Saunders JT, Nambi V, de Lemos JA, Chambless LE, Virani SS, Boerwinkle E, et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 2011;123:1367-76.
10. Potter JM, Koerbin G, Abhayaratna WP, Cunningham RD, Telford RD, Hickman PE. Transient troponin elevations in the blood of healthy young children. Clin Chim Acta 2012;413:702-6.
11. Telford RD, Bass SL, Budge MM, Byrne DG, Carlson JS, Coles D, et al. The Lifestyle Of Our Kids (LOOK) project: outline of methods. J Sci Med Sports 2009;12:156-63.
12. Southcott EK, Kerrigan JL, Potter JM, Telford RD, Waring P, Reynolds GJ, et al. Establishment of pediatric reference intervals on a large cohort of healthy children. Clin Chim Acta 2010;411:1421-7.
13. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
14. Kavsak PA, MacRae AR, Yerna MJ, Jaffe AS. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem 2009;55:573-7.
15. Koerbin G, Tate J, Potter JM, Cavanaugh J, Glasgow N, Hickman PE. Characterization of a highly sensitive TnI assay and its application to a cardiohealthy population. Clin Chem Lab Med 2012;50:871-8.
16. Fokkema MR, Herrmann Z, Muskiet FAJ, Moecks J. Reference change values for brain natriuretic peptides revisited. Clin Chem 2006;52:1602-3.
17. Chan MK, Seiden-Long I, Aytekin M, Quinn F, Ravalico T, Armbruster D, Adeli K. Canadian Laboratory Initiative on Paediatric Reference Interval Database (CALIPER): paediatric reference intervals for an integrated clinical chemistry and immunoassay analyzer, Abbott ARCHITECT ci8200. Clin Biochem 2009;42:885-91.
18. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S, et al. Evidence for cardiomyocyte renewal in humans. Science 2009;324:98-102.
19. Apple FS. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009;55:1303-6.
20. Hickman PE, Potter JM, Aroney C, Koerbin G, Southcott E, Wu AH, Roberts MS. Cardiac troponin may be released by ischemia alone, without necrosis. Clin Chim Acta 2010;411:318-23.
21. Apple FS, Collinson PO. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012;58:54-61.
22. Wu AHB, Akhigbe P, Wians F. Long-term biological variation in cardiac troponin I. Clin Biochem 2012;45:714-6.
23. Kavsak PA, Newman AM, Lustig V, MacRae AR, Palomaki GE, Ko DT, et al. Long-term health outcomes associated with detectable troponin I concentrations. Clin Chem 2007;53:220-7.
24. th percentile for clinical decision-making. Clin Chem 2009;55:85-92.
25. Campbell B, Badrick T, Flatman R, Kanowski D. Limited clinical utility of high-sensitivity plasma C-reactive protein assays. Ann Clin Biochem 2002;39:85-8.
26. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease. Application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
27. Horowitz GL, Altaie A, Boyd JC, Ceriotti F, Garg U, Horn P, et al. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline. 3rd ed. CLSI C28-A3. Wayne (PA): CLSI; 2008.